Skip to main content
. Author manuscript; available in PMC: 2018 Nov 5.
Published in final edited form as: JAMA Pediatr. 2018 Feb 1;172(2):143–153. doi: 10.1001/jamapediatrics.2017.4043

Table 3.

Patient and Cardiac Arrest Characteristics by Hypotension Groupa

Any Hypotension at 0–72 h
Characteristic Overall (N = 292) No (n = 131) Yes (n = 161) P Value
Age at randomization, median (IQR), mo 23.0 (5.0–105.0) 18.0(5.0–55.0) 25.0(5.0–146.0) .049b
Male, No. (%) 194 (66.4) 85 (64.9) 109 (67.7) .61c
Race, No. (%)
 Black or African American 65 (22.3) 30 (22.9) 35 (21.7) .89c
 White 174 (59.6) 79 (60.3) 95 (59.0)
 Other or unknown 53 (18.2) 22 (16.8) 31 (19.3)
Ethnicity, No. (%)
 Hispanic or Latino 65 (22.3) 26 (19.8) 39 (24.2) .15c
 Not Hispanic or Latino 214(73.3) 96 (73.3) 118 (73.3)
 Unknown 13 (4.5) 9 (6.9) 4 (2.5)
Preexisting chronic conditions, No. (%)
 None 150 (51.4) 78 (59.5) 72 (44.7) .01c
 Prenatal 36 (12.3) 20 (15.3) 16 (9.9) .17c
 Lung or airway disease 66 (22.6) 29(22.1) 37 (23.0) .86c
 Congenital heart disease 35 (12.0) 14 (10.7) 21(13.0) .54c
 Gastrointestinal tract 41 (14.0) 21 (16.0) 20 (12.4) .38c
 Neurologic 49 (16.8) 20 (15.3) 29 (18.0) .53c
 Other 71 (24.3) 24 (18.3) 47 (29.2) .03c
Night or weekend arrest, No. (%) 141 (48.3) 60 (45.8) 81 (50.3) .44c
Initial cardiac arrest rhythm noted by EMS or hospital, No. (%)
 Asystole 172 (58.9) 82 (62.6) 90 (55.9) .61c
 Bradycardia 19 (6.5) 8 (6.1) 11 (6.8)
 PEA 42 (14.4) 19 (14.5) 23 (14.3)
 Ventricular fibrillation or tachycardia 23 (7.9) 7 (5.3) 16 (9.9)
 Unknown 36 (12.3) 15 (11.5) 21 (13.0)
Primary cause of cardiac arrest, No. (%)
 Cardiac 37(12.7) 11 (8.4) 26 (16.1) <.001c
 Respiratory 211 (72.3) 109 (83.2) 102 (63.4)
 Other 10 (3.4) 0 10 (6.2)
 Unknown 34 (11.6) 11 (8.4) 23 (14.3)
Cardiac arrest witnessed, No. (%) 108 (37.0) 38 (29.0) 70 (43.5) .009c
Chest compressions administered by bystander, No. (%) 183 (62.7) 94 (71.8) 89 (55.3) .01c
Estimated duration of chest compressions, No. (%)
 ≤15 min 66 (22.6) 24 (18.3) 42 (26.1) .053c
 >15to≤30min 109 (37.3) 60 (45.8) 49 (30.4)
 >30min 106 (36.3) 42 (32.1) 64 (39.8)
 Unable to be determined 11 (3.8) 5 (3.8) 6 (3.7)
Total No. of doses of epinephrine administered by EMS and at hospital, No. (%)
 0 19 (6.5) 9 (6.9) 10 (6.2) .57c
 1 35 (12.0) 18 (13.7) 17 (10.6)
 2 51 (17.5) 24 (18.3) 27 (16.8)
 3 40 (13.7) 21 (16.0) 19 (11.8)
 4 41 (14.0) 17 (13.0) 24 (14.9)
 >4 76 (26.0) 28 (21.4) 48 (29.8)
 Missing 30 (10.3) 14 (10.7) 16 (9.9)
Time from ROSC to TTM initiation, median (IQR), h [No. of participants] 5.8 (5.1–6.5) [292] 5.8(5.2–6.6) [131] 5.8 (5.0–6.5) [161] .47b
Treatment received, No. (%)
 Hypothermia 153 (52.4) 67 (51.1) 86 (53.4) .70c
 Normothermia 139 (47.6) 64 (48.9) 75 (46.6)
Burden of hypotension, median (IQR), % [No. of participants] (292)1.4 (0.0–7.8) 0.0 (0.0–0.0) [131] 6.7 (2.9–18.8) [161] <.001b
Maximum measured lactate level, median (IQR), mmol/L [No. of participants] 4.4 (2.3–7.7) [285] 3.9(1.9–6.1) [128] 5.3 (2.8–9.0) [157] <.001b
Minimum measured lactate level, median (IQR), mmol/L [No. of participants] 1.2 (0.8–2.1) [285] 1.2 (0.8–1.7) [128] 1.2 (0.8–2.6) [157] .16c
No medications, No. (%) 78 (26.7) 50 (38.2) 28 (17.4) <.001c
No. of vasoactive agents administered, No. (%)
 0 98 (33.6) 59 (45.0) 39 (24.2) <.001c
 1 77 (26.4) 38 (29.0) 39 (24.2)
 2 100 (34.2) 28 (21.4) 72 (44.7)
 3 17 (5.8) 6 (4.6) 11 (6.8)
Milrinone administered, No. (%) 36 (12.3) 11 (8.4) 25 (15.5) .07c
Corticosteroids administered. No. (%) 57(19.5) 16(12.2) 41 (25.5) .004c
Vasopressin administered, No. (%) 68 (23.3) 26 (19.8) 42 (26.1) .21c

Abbreviations: EMS, emergency medical services; IQR, interquartile range; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; TTM, targeted temperature management.

a

Indicates hypotension at 0 to 72 hours. Percentages have been rounded and may not total 100.

b

Calculated using the Wilcoxon rank sum test.

c

Calculated using the χ2 test of no association.